BRCA1 and neoplasm: Recent investigations have revealed that approximately 25% of patients with mCRPC harbor tumor somatic or germline mutations in DNA damage repair (DDR) genes including breast cancer susceptibility genes BRCA1 and BRCA2, as well as other genes implicated in homologous recombination repair (HRR) [4].